checkAd

    C21 Investments - Superstarker Potdeal - 500 Beiträge pro Seite

    eröffnet am 30.01.18 11:51:57 von
    neuester Beitrag 29.06.21 15:22:41 von
    Beiträge: 95
    ID: 1.272.836
    Aufrufe heute: 2
    Gesamt: 3.819
    Aktive User: 0

    ISIN: CA12675Q1019 · WKN: A2JSK2 · Symbol: CXXIF
    0,3570
     
    USD
    +7,69 %
    +0,0255 USD
    Letzter Kurs 01:10:00 Nasdaq OTC

    Werte aus der Branche Pharmaindustrie

    WertpapierKursPerf. %
    0,7500+50,00
    3,8000+38,18
    3,6600+33,58
    1,2500+22,55
    0,6393+21,19
    WertpapierKursPerf. %
    2,7000-10,00
    31,00-13,60
    3,8500-16,12
    1,4600-27,00
    3,6400-38,62

     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 30.01.18 11:51:57
      Beitrag Nr. 1 ()
      Hier entsteht ein neuer Pot-Bluechip!


      C21 to acquire two pot operations in U.S., complete COB

      2018-01-29 20:26 ET - News Release

      Mr. Robert Cheney reports

      C21 ANNOUNCES PROPOSED CHANGE OF BUSINESS, CONVERTIBLE DEBENTURE FINANCING AND INTENTION TO LIST SECURITIES ON THE CSE

      C21 Investments Inc. intends to complete a change of business, subject to receipt of acceptance from a majority of its shareholders, spearheading into the U.S. cannabis industry and focusing on revenue-producing operations. C21 further intends to apply to list its common shares on the Canadian Securities Exchange ("CSE"), and delist from the NEX board of the TSX Venture Exchange ("TSX-V").

      Change of Business Overview and Convertible Debenture Financing

      To maximize shareholder value, C21's management and its Board of Directors (the "BOD") made the strategic decision to enter into two definitive agreements (the "Definitive Agreements") to acquire substantial cannabis cultivation and distribution operations in Oregon and Maine (the "Acquisitions").

      In conjunction with the Acquisitions (which are more particularly described below), the Company intends to complete a non-brokered private placement for gross proceeds of a minimum of Cdn$7,425,000 and up to Cdn$40,000,000 (the "Financing").

      These funds will be raised by the Company issuing an aggregate principal amount of up to Cdn$40,000,000 of secured convertible debentures (the "Debentures"), maturing 24 months after closing of the Financing (the "Maturity Date"). From and after the date of issue until the Maturity Date, the Debentures will be convertible into common shares (the "Conversion Shares") at the option of the holder at a conversion price of $1.00 per shares (the "Conversion Price").

      However, upon completion of the Acquisitions, Change of Business, Financing and listing on the CSE, and subject to receipt of any required regulatory and shareholder approvals, at any time on or after closing the Company may elect to force conversion of the then outstanding principal amount of Debentures into Conversion Shares.

      Interest on the Debentures shall be calculated semi-annually in arrears, at an annual rate of interest of 8% per annum.

      The Debentures will be secured by a security interest on all present and after acquired property and assets of the Company in favour of a trustee on behalf of the holders of the Debentures.

      The proceeds from the Financing will be used towards expenses required with respect to the Acquisitions and for general working capital.

      In connection with the Financing, finders' fees equal to up to 5.0% of proceeds raised may be paid in cash, in addition to such other fee(s) as may be agreed to by the Company and approved by the applicable stock exchange.

      Subject to any required regulatory approvals, the Company intends to pay each subscriber that participates in the Financing a loan bonus by issuing to each subscriber that number of shares as is equal to 10% of the total number of shares issuable to each subscriber upon conversion of the Debentures purchased under the Financing by such subscriber (the "Bonus Shares"), to be issued at a deemed value of $1.00 per Bonus Share.

      One Insider (the "Related Party") has indirectly subscribed for total principal amount of $420,000 from the Financing, and accordingly if and when converted into Shares and Bonus Shares are issued, will increase that Related Party's pro rata shareholdings in the Company (the "Related Party Transaction"). All of the independent directors of the Company, acting in good faith, have determined that the fair market value of the securities being issued and the consideration paid is reasonable and, with the value of the Related Party Transaction being less than 25% of the Company's market capitalization, is exempt from the formal valuation and minority shareholder approval requirements of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions.

      With respect to the Financing, under applicable Canadian securities law the securities and underlying securities to be issued will be subject to a hold period of four months and a day from the date of issuance of the securities, and will be subject to such further restrictions on resale as may apply under applicable foreign securities laws.

      Intention to De-List from TSX-V and Seek Listing on the CSE

      In connection with the Acquisitions and subject to consent of a majority of shareholders of the Company, the Company will apply to list its common shares on the CSE, which application is subject to the Company meeting the CSE's listing requirements. There is no assurance that the CSE will provide conditional or final approval of the Company's application to list its common shares on the CSE. The Company will concurrently apply to delist its common shares from the TSX-V, subject to TSX-V acceptance.

      Following closing of the Acquisitions and closing of the maximum Financing and conversion of the Debentures by the issuance of a maximum of 40,000,000 Conversion Shares, as well as the issuance of a maximum of 4,000,000 Bonus Shares, it is anticipated that the Company will have 50,000,000 common shares issued and outstanding, excluding any shares that may be issued on exercise of stock options entitling optionees to purchase up to 505,000 common shares that are currently outstanding. The Company has no share purchase warrants outstanding at the present time.

      Further details regarding the Change of Business will be outlined in the disclosure document to be submitted by the Company to the CSE and filed on SEDAR. The Change of Business and CSE listing is contingent on receipt of shareholder consent. The Company is confident it will secure consent from a majority of its shareholders in this regard.

      As at the time of the Acquisitions the Company's management and BOD, are comprised of the following:

      Robert Cheney, President, Chief Executive Officer and Director, has over 35 years within the business industry, and who obtained his law degree from UBC and BA from Simon Fraser University. Mr. Cheney has extensive experience as an entrepreneur forming and leading new ventures globally. Through his career, Mr. Cheney acted for several prominent emerging companies in mining, technology and films, as well as global investment firms, such as Charterhouse. Since the 1980's Mr. Cheney has been focussed in the business industry as an investor and venture capitalist.

      Christopher Cherry, Chief Financial Officer and Director, has over 14 years of corporate accounting and audit experience. Mr. Cherry has extensive corporate experience and has held senior-level positions for several public mining companies, including director, CFO and secretary. Mr. Cherry has been a chartered accountant since February 2009, and a certified general accountant since 2004. In his former experience as an auditor, he held positions with KPMG and Davidson and Co. LLP in Vancouver, where he gained experience as an auditor for junior public companies and as an initial public offering specialist.

      Leonard Werden, Director, is an experienced horticultural cultivation expert with over 35 years of experience in British Columbia and internationally. Mr. Werden advises on grow practices, facilities construction and design, lighting systems selection and installation, irrigation systems and practices, temperature and humidity control and genetic strain selection. Mr. Werden has developed and supervised large-scale grow operations with state of the art technology. Mr. Werden has an intimate understanding of indoor and outdoor grow practices.

      Keturah Nathe, Director, has over 11 years' experience with various public and private companies in industries involving mineral exploration and development, oil and gas, technology and agriculture. Ms. Nathe currently is acting as Vice President of Corporate Development for Simco Services Inc., and Iconic Minerals Ltd.

      In accordance to the Definitive Agreements, the Vendors have the option to appoint an person of their choosing to sit on the BOD.

      The Acquisitions and funding, represent the first stage of C21's investment strategy to acquire several, established, revenue-producing, cannabis operations, with proven management teams, who have the ability to expand and support such operations with the new investment capital. The near-term Company target, is to establish vertically integrated business operations, with high quality cultivation, processing, branding, and wide retail dispensary distribution.

      Oregon Acquisition Terms

      On January 19, 2018, C21 signed a Definitive Agreement for the Acquisition of Proudest Monkey Holdings, LLC, (the "Eco Firma Farms Oregon" or "Oregon Operations"). For the Acquisition of the Oregon Operations, C21 will issue convertible notes entitling the current owners to receive up to 4.3 million shares of the Company at a deemed value of CDN$1.00 per Converted Share. The note as to 2.3 million shares has no cash value and bears no interest. The note as to 2 million shares has a cash redemption value of US$2 million and bears interest at 4% per cent per annum.

      In addition to the above notes the Company has entered into a lease agreement entitling C21 to acquire full legal interest in the property, structures and leasehold improvements for US$4 million. The Vendors have the option to receive 4 million shares in lieu of the cash at the time of the purchase of the property.

      Accordingly, in total the vendors of the business and the real property collectively can receive a total of up to 8.3 million shares of the company in the event they convert all their notes and elect to receive all shares in exchange for the real property and improvements.

      In addition to the 8.3 million consideration shares described above the vendors in Oregon can also earn shares for producing EBIDTA earnings over a five-year period. Up to 10 million shares can be earned in total over the five-year term with a maximum of 2 million shares earned per year. One share shall be issued for each US$5.00 of EBIDTA generated so long as the wholesale price of cannabis remains above US$1,750.00 per pound equivalent. In the event the average wholesale selling price of cannabis received by the business is between US$1,500.00 and US$1,7499.00 per pound equivalent then one share shall be earned for each US$3.75 of EBIDTA. If the average wholesale selling price of cannabis received by the business is between US$1,400 and US$1,499.99 per pound equivalent then one share shall be earned for each US $2.50 of EBIDTA. In the even the whole sale price of cannabis received by the business falls below $1,400 per pound equivalent then an additional year will be added to the earn out term.

      In order to mitigate grow risk and ensure higher wholesale prices C21 plans to open and manage its own retail dispensary outlets in Oregon.

      The conditions to closing the Acquisition of Eco Firma Farms (Oregon), C21 must receive approval to list on the CSE.

      Maine Acquisition Terms

      On January 5, 2018, C21 signed a Definitive Agreement for the Acquisition of North American Health Group, LLC and New England Manufactured and Supply, LLC (the "Eco Firma Farms Maine" or "Maine Operations"). For the Acquisition of the Maine Operations, C21 will issue convertible notes entitling the current owners, to receive up to 8.3 million shares of the Company at a deemed value of CDN$1.00 per converted share. The note as to 6.3 million shares has no cash value and bears no interest. The note as to 2 million shares has a cash redemption value of US$2 million and bears interest at 4% per cent per annum.

      In addition to the above notes the company has entered into a lease agreement entitling C21 to acquire full legal interest in the property, structures and leasehold improvements for US$2 million. The vendor owners of Blue Water Marina LLC have the option to receive 2 million shares in lieu of the cash at the time of the purchase of the property.

      Accordingly, in total the vendors of the business and the real property collectively can receive a total of up to 10.3 million shares of the company in the event they convert all their notes and elect to receive all shares in exchange for the real property and improvements.

      In addition to the 10.3 million consideration shares described above the vendors in Maine can also earn shares for producing EBIDTA earnings over a seven-year period. Up to 8 million shares can be earned in total over the seven-year term with a maximum of 2 million shares earned per year. One share shall be issued for each US$5.00 of EBIDTA generated so long as the wholesale price of cannabis remains above US$1,750.00 per pound equivalent. In the event the average wholesale selling price of cannabis received by the business is between US$1,500.00 and US$1,7499.00 per pound equivalent then one share shall be earned for each US$3.75 of EBIDTA. If the average wholesale selling price of cannabis received by the business is between US$1,400 and US$1,499.99 per pound equivalent then one share shall be earned for each US $2.50 of EBIDTA. In the even the whole sale price of cannabis received by the business falls below $1,400 per pound equivalent then an additional year will be added to the earn out term.

      In order to mitigate grow risk and ensure higher wholesale prices C21 plans to open and manage its own retail dispensary outlets in Maine.

      The conditions to closing the Acquisition of Eco Firma Farms (Oregon), C21 must receive approval to list on the CSE.

      About Oregon Operations

      The Company's impending acquisition of Eco Firma Farms Oregon, involves an approximately 20-acre cultivation site with a building structure providing approximately 26,000 square feet of available indoor grow, processing and office space. The Company is acquiring a 100% interest in the business holding company, Proudest Monkey Holdings LLC, and a 100% interest the property holding company, Covered Marina LLC, under a put/call option lease agreement. Details of the transaction are set out below. Initially the company will occupy the land and premises under a lease with an option to buy.

      To date several commercial indoor crop cycles have been successfully completed. The Oregon facility is currently producing cannabis at a rate of approximately 2,400 pounds per annum. Oregon's cultivation team is led by experienced cannabis cultivators with combined experience of over 20 years in the industry. The Company intends to double Oregon's indoor production capacity within nine months from the closing of the Acquisitions. Additional out door grow operations including greenhouses and processing will also be included in the 2018 expansion program. This increased capacity will allow for the production of cannabis oil and the processing of branded bakery and edible products. The 2019 production is targeted to be 5,000 to 6,000 pounds of high quality indoor flower. C21 is allocating US$5 million of new investment towards expanding grow and processing operations as well as greater distribution bandwidth within the next twelve months in Oregon. The Oregon facilities are fully licenced for cannabis cultivation under Oregon state law. Jesse Peters the President of Eco Firma Farms commented on the merger: "We are excited to see what the future holds as we expand the footprint of Oregon cannabis here and abroad with the backing of new investment capital from C21."

      About Maine Operations

      The impending acquisition of Eco Firma Farms Maine, is located on an approximately 80-acre site with approximately 125,000 square feet of available indoor grow and processing operations. The acquisition is being effected through the acquisition of a 100% interest in North American Health Group LLC and of a 100% interest in the real estate assets through a put/call option agreement to acquire 100% of Blue Water Marina LLC.

      C21's planned expansion in Maine includes additional outdoor cultivation to be built on site with 13 acres currently securely fenced to comply with state regulations. Greenhouses will also be constructed as well as expansion of processing operations. A State of Maine permit has been granted for a 4,500-square foot processing lab to be constructed. Commercial production from indoor operations of cannabis flower is targeted at 4,000 pounds for 2018 and 6,000 pounds for 2019 following the phase 2 expansion. Establishing outdoor cultivation, greenhouse cultivation, oil production, processing operations, and branded products, offers C21 significant revenue diversification and upside revenue potential for the Maine operations. The Company is also considering producing CBD's with hemp cultivation in Maine to fully utilize the additional outdoor acreage. Kevin Dean, the President of North American Health Group and New England Manufacturing and supply said: "We are excited about the sale of our companies to C21. Joining forces will allow us to pursue our aggressive growth plans with a well-capitalized company and great management team".

      The Industry

      The cannabis industry in the United States is a new and exciting industry with projected rapid expansion. The majority of the states within in the USA, now have some form of state sponsored cannabis legalization and the general regulatory trend is moving towards further legalization. The projected revenues for the USA cannabis industry are estimated at US$5+ Billion for 2018 and could rise to $17+ Billion by 2021, according to the Marijuana Business Factbook. The tax revenues generated by the industry and the new high-skilled jobs created have been integral to economic growth for several US states. It is estimated approximately 280,000 new jobs relating to cannabis could be created in the US by 2020.

      "Near term growth prospects for the industry are very strong with double-digit market growth projected for the next few years. C21 has a strategy to participate in this exciting growth through timely acquisitions of established cannabis businesses with top-line revenue growth potential and EBIDTA." said Cheney, C21's President and CEO.

      C21's acquisition strategy focuses on jurisdictions where cannabis cultivation, processing and distribution are legal under local state and municipal law. The cannabis operations being acquired by C21 undertake rigorous internal compliance standards in order to remain fully legally compliant with all state and local laws and regulations.

      Canadian Companies with U.S. Marijuana-Related Assets

      On October 16, 2017, the Canadian Securities Administrators published Staff Notice 51-352 — Issuers with U.S. Marijuana-Related Activities ("Staff Notice 51-352") which provides specific disclosure expectations for reporting issuers in Canada that currently have, or are in the process of developing, marijuana-related activities in the United States as permitted within a particular state's regulatory framework. All reporting issuers with U.S. marijuana-related activities are expected to clearly and prominently disclose certain prescribed information in prospectus filings and other applicable disclosure documents in order to fairly present all material facts, risks and uncertainties about issuers with U.S. marijuana-related activities.

      Upon completion of the Acquisitions, the Company will have direct involvement in cultivation or distribution of cannabis in the United States as it will own the business and operations of at least two licensed producers of cannabis.

      Unlike in Canada, which has federal legislation uniformly governing the cultivation, distribution, sale and possession of medical cannabis under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), in the United States, cannabis is largely regulated at the state level. To the Company's knowledge, there are to date a total of 29 states, plus the District of Columbia, Puerto Rico and Guam that have legalized cannabis in some form. Notwithstanding the permissive regulatory environment of medical cannabis at the state level, cannabis continues to be categorized as a Schedule I controlled substance under the United States Controlled Substances Act (the "CSA") and as such, violates federal law in the United States.

      As a result of the conflicting views between state legislatures and the United States federal government regarding cannabis, investments in cannabis businesses in the United States are subject to inconsistent legislation and regulation. The response to this inconsistency was addressed in August 2013 when then Deputy Attorney General, James Cole, authored a memorandum (the "Cole Memorandum") addressed to all United States district attorneys acknowledging that notwithstanding the designation of cannabis as a controlled substance at the federal level in the United States, several US states have enacted laws relating to cannabis for medical purposes. The Cole Memorandum outlined certain priorities for the Department of Justice relating to the prosecution of cannabis offenses. In particular, the Cole Memorandum noted that in jurisdictions that have enacted laws legalizing cannabis in some form and that have also implemented strong and effective regulatory and enforcement systems to control the cultivation, distribution, sale and possession of cannabis, conduct in compliance with those laws and regulations is less likely to be a priority at the federal level.

      However, on January 4, 2018, Jefferson Sasson, the United States Attorney General issued a memo to all United States district attorneys rescinded the Cole Memorandum in its entirety (the "Sasson Memo"). The Sasson Memo provided that in deciding which marijuana activities to prosecute under United States federal laws, prosecutors should follow the well-established principles that govern all federal prosecutions; including requiring prosecutors to decide which cases to prosecute to weigh all relevant considerations, including federal law enforcement priorities set by the Attorney General, the seriousness of the crime, the deterrent effect of criminal prosecution, and the cumulative impact of particular crimes on the community. Since the release of the Sasson Memo, the footing for an interpretation on how to treat state legalized cannabis is less clear. The risk of how each state will treat cannabis will be based on the district attorneys for the applicable state. Even if a state in which the Company operates or holds assets permits cannabis cultivation, the United States district attorney can decide that such cultivation or sales are in contravention of United States federal law and initiate prosecution against the Company.

      Violations of any federal laws and regulations could result in significant fines, penalties, administrative sanctions, convictions or settlements arising from civil proceedings conducted by either the federal government or private citizens, or criminal charges, including, but not limited to, disgorgement of profits, cessation of business activities or divestiture. This could have a material adverse effect on the Company, including its reputation and ability to conduct business, its holding (directly or indirectly) of medical cannabis licenses in the United States, the listing of its securities on various stock exchanges, its financial position, operating results, profitability or liquidity or the market price of its publicly traded shares. In addition, it is difficult for the Company to estimate the time or resources that would be needed for the investigation of any such matters or its final resolution because, in part, the time and resources that may be needed are dependent on the nature and extent of any information requested by the applicable authorities involved, and such time or resources could be substantial.

      As the Company operates in Canada and is listed on Canadian TSX-V, with application to migrate to the CSE, it will be able to access the Canadian capital markets on a public and private basis; such capital may be utilized for the ongoing operations of the its United States holdings that operate in the cannabis industry. Although such investments carry a higher degree of risk, and despite the illegal nature of cannabis under United States federal laws, Canadian based issuers involved in making U.S. cannabis based investments have been successful in raising substantial amounts of private and public financing. However, there is no assurance the Company will be successful, in whole or in part, in raising funds, particularly if the U.S. federal authorities change their position toward enforcing the CSA. Further, access to funding from U.S. residents may be limited due their unwillingness to be associated with activities which violate US federal laws.

      The Company's investments in entities involved in the United States cannabis industry will be made: (i) only in those states that have enacted laws legalizing cannabis in an appropriate manner; and (ii) only in those entities that have fully complied with such state (and local) laws and regulations and have the licences, permits or authorizations to properly carry on each element of their business.

      Once the Acquisitions are complete, the Company will implement measures designed to ensure compliance with applicable U.S. state laws on an ongoing basis, including:frequent correspondence and updates with legal and regulatory advisors;development of standard operating procedures;appropriate employee training for all standard operating procedures; andsubscription to monitoring programs with large banks to monitor and ensure compliance with the United States Treasury guidelines for cannabis-related businesses.

      The Company has required representations and warranties for the Acquisitions that the businesses being carried on are conducted in a manner consistent with the U.S. federal enforcement priorities and such entities are in compliance with licensing requirements and applicable state regulatory frameworks.

      We seek Safe Harbor.
      Avatar
      schrieb am 17.09.18 11:50:07
      Beitrag Nr. 2 ()
      Avatar
      schrieb am 22.09.18 18:54:47
      Beitrag Nr. 3 ()
      C21 fundamental unterbewertet! 2018 macht C21 schon über 30 Mio Umsatz!!!
      Avatar
      schrieb am 24.09.18 22:37:56
      Beitrag Nr. 4 ()
      Avatar
      schrieb am 24.09.18 22:39:38
      Beitrag Nr. 5 ()
      C21’s revenue is bigger than Canopy Growth & Aurora combined
      C21 has a projected annual revenue of $70M USD – almost that of Canopy Growth ($30.9), Tilray ($20M) and Aurora ($31.9M) combined and they are about to start trading in the US.

      Bill Griffin, 24 September 2018

      C21 Investments are one of the best kept secrets of the emerging cannabis industry. Michael Kraland, of Cannabis Capital Convention, caught up with Robert Cheney, CEO of C21 on Sunday 23 September in Amsterdam.

      C21 Investments are a vertically integrated cannabis company building an impressive portfolio of brands in Canada and the US and is one of the largest CBD companies in the world.

      Cheney’s in Amsterdam attending and speaking at Cannabis Capital Convention, “to meet shareholders, investors and potential new investors to tell people about the opportunity of C21 to participate in the cannabis and CBD industry. With a company that has not only scaled with many brands and products but is also one of the very few profitable companies in the industry.”

      Trading Spotlight

      Anzeige
      Rallye II. – Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…mehr zur Aktie »
      Avatar
      schrieb am 07.10.18 14:07:17
      Beitrag Nr. 6 ()
      mal eben so von Bruce Campbell zum "top pick" erklärt worden.... kann man machen :-)


      https://www.bnnbloomberg.ca/video/bruce-campbell-s-top-picks…
      Avatar
      schrieb am 09.10.18 07:50:07
      Beitrag Nr. 7 ()
      CBD-Schokolade :)

      "deepest darkest chocolate..."

      "Grön Chocolate" ist ein Sub von C21.

      https://www.bonappetit.com/gallery/five-cbd-chocolates
      Avatar
      schrieb am 14.10.18 11:51:27
      Beitrag Nr. 8 ()
      Moin @shamane

      ich verfolge C21 Investments Inc. schon eine ganze Weile. Ich bin seinerzeit über Keturah Nathe, VP Corporate Development & Director auf CXXI aufmerksam geworden, da sie ebenfalls VP Corporate Development bei einem anderen Unternehmen ist in welchem ich investiert bin.




      Ich hatte ursprünglich vor um CAD 1.00 eine erste Position aufzubauen (ein Teil der Warrants hatte einen Ausübungspreis von CAD 1.00), bevor der Wert "entdeckt" wird, jedoch hat der Kurs nach dem kurzen Dip unter CAD 1.00 die Aufmerksamkeit einer Tradergruppe auf Twitter erlangt und der Kurs zog in der Folge stark an und ich war nicht bereit den Aufschlag unter diesen Voraussetzungen zu bezahlen.

      Zuletzt hat C21 Investment Inc. wieder ein wenig korrigiert (aktuell CAD 1.39) und mit dem anstehenden US Listing (überfällig - rechne kommende Woche damit) und mit den ersten Transaktionen, die vorraussichtlich in Kürze abgeschlossen sein werden, rechne ich mit einer Neubewertung.







      Ich bin der Meinung, dass dies auch durch die vertikale Integration eine sehr vielversprechende Story ist über die man sich durchaus mal "informieren" kann. Die Website ist sehr ansprechend und enthält alle wesentlichen Informationen.

      C21 Investments Inc. (CSE – CXXI). is a vertically integrated cannabis corporation that cultivates,
      processes, manufactures, and distributes quality cannabis and hemp-derived consumer products with brand recognition both in the United States and internationally.
      www.cxxi.ca

      Nachfolgend der direkte Link zur aktuellsten Unternehmenspräsentation:
      https://cxxi.ca/wp-content/uploads/2018/09/C21_PitchDeck_9-1…

      Nachfolgen der direkte Link zum "President's shareholder letter":
      https://cxxi.ca/wp-content/uploads/2018/08/C21AGMPresidentsL…

      Dieses Interview gibt ebenfalls einen guten Überblick über die Entwicklungen rund um CXXI.

      Rob Chaney - Cannabis Stocks Reaching for New Highs #3996


      Am 13.08.2018 veröffentlicht

      "Rob Chaney CEO and Director of our new sponsor C21 Investments is bullish on the Cannabis industry's growth. It's no secret that the industry is expanding rapidly and Rob is expecting it to grow from $11 billion per year now to $23 billion in 3 short years. The company is ideally positioned to catch the wave. It's vertically integrated and is currently profitable. It's making strategic acquisitions in the US and has first rate manufacturing capabilities. The management is experienced in the horticultural space and is building first rate branded products. With this kind of potential and market growth, the sky's the limit for C21! It's traded on the Canadian Securities Exchange CSE and it's symbol is CXXI."

      Ich möchte an diese Stelle anmerken, dass ich auch zum jetzigen Zeitpunkt keine Aktien dieser Firma halte.

      Gruß phobieeee
      Avatar
      schrieb am 15.10.18 10:10:28
      Beitrag Nr. 9 ()
      GOODmoaning.
      Avatar
      schrieb am 16.10.18 22:06:48
      Beitrag Nr. 10 ()
      C21 Announces Stock Option Grant
      Vancouver, British Columbia--(Newsfile Corp. - October 16, 2018) - C21 Investments Inc. (CSE: CXXI) (the "Company" or "C21") announces the grant, pursuant to its 10% Rolling Stock Option Plan, of options to a certain eligible consultant to purchase a total of 75,000 common shares, exercisable in whole or in part at $1.33 per share on or before October 15, 2020.

      ON BEHALF OF THE BOARD

      SIGNED: "Michael Kidd"

      Michael Kidd, CFO, Secretary, Director
      For more information contact:
      Michael Kidd Tel: (604) 336-8613
      www.cxxi.ca

      The CSE has not accepted responsibility for the adequacy or accuracy of this release.
      Avatar
      schrieb am 17.10.18 14:42:58
      Beitrag Nr. 11 ()
      BNN Bloomberg Promotion startet...
      https://twitter.com/Jimbolt5/status/1052246341815074816

      Gruß phobieeee
      Avatar
      schrieb am 18.10.18 18:23:00
      Beitrag Nr. 12 ()
      C21 Investments enters into definitive agreement for the acquisition of cannabis firm, Phantom Farms


      VANCOUVER, Oct. 18, 2018

      Legacy cannabis brand to strengthen C21 Investments brand portfolio

      VANCOUVER, Oct. 18, 2018 /CNW/ - C21 Investments Inc. (CSE: CXXI) (FSE: C6QP) today announced that it has entered into definitive agreements for the June 18, 2018 announced acquisition of Phantom Venture Group LLC and Phantom Brands LLC (together "Phantom Farms") and SDP Development Group, LLC ("SDP"), the owner of the real property used in the Phantom Farms business.

      C21 Investments Inc. (CNW Group/C21 Investments Inc.)

      Phantom Farms has outdoor cannabis cultivation facilities totalling 80,000 square feet plus an additional 40,000 square feet under development in Southern Oregon. In addition, they operate a 5,600-square foot facility which includes a wholesale distribution warehouse and an extraction laboratory, plus a 7,700 square foot state of the art indoor grow facility in Central Oregon. SDP currently leases such property to Phantom Farms.

      "Phantom Farms is a high-quality operation with a talented team producing some of the finest products in Oregon," said Robert Cheney, President and CEO of C21 Investments. "Phantom Farms is among several successful companies set to join C21 Investments in order to make us a world-class, vertically integrated cannabis company."

      "We are excited to be part of a growing company with passionate employees who are committed to the quality of the products they produce and the communities they serve," said Sky Pinnick, CEO of Phantom Farms. "Joining C21 Investments will enable us to expand our operations and establish our brand as a powerhouse in the global cannabis industry."

      C21 Investments' strategy is to acquire existing and successful cannabis operations with experienced management teams in place. C21 Investments' focus is to expand into jurisdictions where it can wholly own indoor/outdoor cultivation operations, processing/extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.

      Terms of Phantom Farms Acquisition
      The Phantom Farms acquisition is subject to prior approval of the Oregon Liquor Control Commission ("OLCC") which is expected to be received in approximately 3 months, with closing to occur following receipt of approval. On closing, C21 Investments will acquire 100% of Phantom Farms' membership units. The aggregate purchase price payable is (1) US$8,010,000 payable by the issue of 2,670,000 common shares ("shares") at a deemed price of USD$3.00 per share, (2) 2,000,000 share purchase warrants of C21 Investments, with each warrant exercisable for one share at a price of CAD$1.50 per share, and (3) up to an additional 4,500,000 shares upon C21's Oregon business achieving certain performance targets over up to a 7-year period following the closing date.

      Terms of SDP Acquisition
      Closing of the acquisition of the SDP membership interests has been deferred until October, 2020. Until then, Phantom Farms will continue to lease the real property from SDP at market rents. On closing, C21 Investments will acquire 100% of SDP's membership units for an aggregate purchase price of US$8,010,000 payable in cash, or, at the election of the vendors, in whole or in part by the issue of 2,670,000 shares at a deemed price of USD$3.00 per share.

      About Phantom Farms
      Phantom is a premium legacy cannabis brand based in Oregon, known for its organic cultivation practices, with a focus on quality terpene development. Phantom was awarded 'Best CBD Flower' at the prestigious Dope Cup in 2016 and 2018, and received 'Outstanding Terpenes' at the 2018 Cultivation Classic. www.phantom-farms.com

      ABOUT C21 INVESTMENTS
      C21 Investments Inc. (CSE: CXXI; FSE: C6QP) is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The company owns Eco Firma Farms in Oregon, and has definitive agreements in place that are expected to close in Q4/18 to acquire Silver State Relief in Nevada and Phantom Farms in Oregon, and Letters of intent to acquire and expected to close also in Q4/18 with Swell Companies, Grön Chocolates & Confections, and three dispensaries in Oregon. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. C21 Investments is also in active discussions to acquire additional operations in the USA and globally that will add to the company's ability to compete aggressively in the rapid growth of the cannabis industry and to grow revenue and EBITDA. Based in Vancouver, Canada, C21 can be found at www.cxxi.ca.

      Cautionary Statement:
      Disclaimer: This press release contains "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the Company's future business operation, expectations of gross sales, the opinions or beliefs of management and future business goals, statements regarding the timing and completion of the listing on the CSE and C21's USA Acquisitions. Generally, forward looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to general business, economic and competitive uncertainties, regulatory risks including risks related to the expected timing of the Company's participation in the Adult Use market, market risks, risks inherent in manufacturing operations and other risks of the cannabis industry. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking information. Forward-looking information is provided herein for the purpose of presenting information about management's current expectations relating to the future and readers are cautioned that such information may not be appropriate for other purpose. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws. This Release does not constitute an offer of securities for sale in the United States, and such securities may not be offered or sold in the United States absent registration or an exemption from registration or an exemption from registration.

      The CSE has not accepted responsibility for the adequacy or accuracy of this release, and in no way has passed upon the merits of the Acquisition.

      Avatar
      schrieb am 19.10.18 11:15:00
      Beitrag Nr. 13 ()
      Growers Episode 5 - Phantom Farms

      Am 19.01.2018 veröffentlicht

      A close-knit team of siblings and their friends are carving out space in Oregon’s craft cannabis market with their outdoor permaculture cannabis farm. Meet CEO Sky Pinnick and the team behind Phantom Farms in Bend, Oregon.



      ---

      https://cannabisnow.com/phantom-farms-cultivation-pacific-no…

      http://www.cannabisbusinesstimes.com/article/10-questions-wi…

      Gruß phobieeee
      Avatar
      schrieb am 19.10.18 13:34:53
      Beitrag Nr. 14 ()
      Es kusieren Gerückte, dass kommende Woche bereits ein weiterer "pending Deal" unter Dach und Fach gebracht werden soll. Konkret soll es sich um den am 09.07.2018 angekündigten Deal mit Swell Companies Ltd handeln.

      Untenstehend noch mal die Details des "Term Sheets" zwischen C21 Investments und Swell Companies.

      "C21 Expands Oregon Operations, Acquires Swell Companies Limited

      C21 Investments Inc., (CSE: CXXI) (the “Company” or “C21”) is pleased to announce a strategic partnership and investment of expansion capital into Swell Companies Limited (the “Swell”), one of the most recognized and respected cannabis extraction and consumer packaged goods companies in Oregon.

      Operating since 2015, Swell has demonstrated a commitment to quality, consistent innovation, and execution at scale with some of Oregon’s most recognized brands. Swell manufactures and distributes over 50 unique SKUs, with products available statewide in over 275 licensed retail locations. In 2017, the company shipped over 500,000 product units within Oregon and anticipates more than doubling product units shipped through existing sales channels in 2018.

      Pursuant to the signed term sheet (the “Term Sheet”), C21 will acquire 100% of Swell’s membership units (the “Acquisition”) and has agreed to invest new capital to expand Swell’s manufacturing, branded product, and wholesale operations. The partnership will strengthen C21’s competitive position in Oregon and in nationwide through access to Swell’s highly-skilled technical expertise and established brand. This acquisition will also support the continued growth of quality manufacturing jobs at Swell and related Oregon businesses.

      Swell manufactures, extracts, packages, and distributes all of its products from a centrally located 10,000-square foot facility in Portland, Oregon. Swell also operates a 5,000-square foot distribution warehouse and has expansion rights for an additional 18,000 square feet, adjacent to the primary facility. Swell currently employs 30 full-time industry professionals and prides itself on being one of the first cannabis companies in Oregon to offer comprehensive benefits to all its employees.

      Commenting on the new partnership Alleh Lindquist, Founder and CEO stated, “We believe C21 is uniquely positioned to create the right kind of vertical model – the aggregation of quality 2 stand-alone assets that can be strategically aligned to harmonize the supply chain, diversify risk, build brand equity and maximize long-term value. This is an exciting time to be joining the C21 family of companies.”

      “Partnering with Swell is a significant move in our national rollout strategy, allowing us to rapidly expand extraction and manufacturing capacity across legalized states as well as bridgehead into fast-growing CBD and wellness product opportunities.” said Robert Cheney, C21’s CEO.

      i. Pursuant to the Term Sheet, C21 will be acquiring 100% of Swell membership units a total consideration of $14.7 million USD by way of a convertible note (the “Note”) with C21 common shares (the “Shares”) valued at USD$3.00 per Share convertible into a total of 4,900,000 Shares of C21 over a 24-month period. The Note valued at USD$3,150,000 (1,050,000 shares) is convertible on closing of the transaction (the “Closing”). An additional amount of USD$4,200,000 (1,400,000 Shares) is convertible 18 months from the date of Closing. The remaining amount of the Note valued at USD$7,350,000 (2,450,000 Shares) is convertible 24 months from the date of Closing. The Note has a maximum of USD $5,000,000.00 cash redemption value (the “Redemption Option”) in the event the C21 Shares are trading at less than CDN$3.75 per share over a period of 15 trading days date 24-months from the date of Closing. The Redemption Option, if exercised, will be subject to reasonable notice. The Redemption Option of the Note for cash, or Shares will be subject to rules, policies and regulations set out by the Canadian Securities Exchange (the “CSE”), governing regulatory bodies, including other conditions to be set for in the definitive agreement (the “Definitive Agreement”).

      ii. For additional consideration, $18 million USD of earn-out shares (6 Million Shares valued at USD$3.00 per Share) will be issued over a five-year period upon Swell achieving certain earnout performance targets to be defined in the Definitive Agreement. In addition to the earn-out Shares, the unit holders of Swell will be granted options to purchase 1,050,000 Shares of C21 at a deemed price of CDN$2.20 per Share for a period of 24 months from Closing. All Shares that may be issued under the terms of the Acquisition will be subject to the CSE policies.

      The deferred note conversion terms and the five-year earn-out targets are intended to align management and shareholder interests and focus the team on executing C21’s rapid growth plan.

      Closing is expected to occur in Q2 2018, conditional upon completion of due diligence and regulatory approval.

      Swell is a growing and Extraction, manufacturer and distribution in a high growth cannabis sector of THC and CBD products within Oregon. Swell currently produces raw oil, encapsulated and vaporizer products under the in-house brands; Swell, Dab Society and Hood Oil, while also providing contract manufacturing and distribution for a select group of best-in-class brands 3 such as, Quill, OCO, and Apothecanna. Swell is a founding board member of the Oregon Cannabis Association, active at the state and local jurisdictional level with agency rule-making, and further supports a variety of economic development and community non-profit organizations. Swell’s established reputation for innovation and quality manufacturing and extraction of THC and CBD consumer packaged goods positions the company for high potential growth in the rapid developing US cannabis markets.

      Cautionary Statement:

      Disclaimer: This press release contains “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the Company’s future business operation, expectations of gross sales, the opinions or beliefs of management and future business goals. Generally, forward looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those 4 expressed or implied by such forward-looking information, including but not limited to general business, economic and competitive uncertainties, regulatory risks including risks related to the expected timing of the Company’s participation in the Adult Use market, market risks, risks inherent in manufacturing operations and other risks of the cannabis industry. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forwardlooking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking information. Forward-looking information is provided herein for the purpose of presenting information about management’s current expectations relating to the future and readers are cautioned that such information may not be appropriate for other purpose. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws. This Release does not constitute an offer of securities for sale in the United States, and such securities may not be offered or sold in the United States absent registration or an exemption from registration."

      ---

      Website:
      http://www.swellcompanies.limited/

      Oktober Präsentation:
      https://cannabiscapitalconvention.eu/wp-content/uploads/2018…

      Interessanterweise steht Swell bereits mit "Phantom Pharms" + "Eco Firma Farms" als Supplier
      sowie "Grön" + "Phantom Pharms" als Brand Partner in direktem Kontakt.




      Gruß phobieeee
      Avatar
      schrieb am 21.10.18 14:17:58
      Beitrag Nr. 15 ()
      C21 Investments leads international cast of speakers at Cannabis Capital Convention in Amsterdam
      AMSTERDAM, Sept. 25, 2018 /CNW/ - Canadian cannabis stocks will be on the minds of European investors tomorrow at the prestigious Cannabis Capital Convention in Amsterdam as four executives from a single Canadian company take center stage to talk about their plans to build a vertically integrated cannabis company.

      In addition to C21 Investments, the convention will feature presenters from a wide range of international organizations including Bedrocan International, Berenberg Bank, Canaccord Genuity, Cannabis Industry Europe, Palo Verde Global, Prohibition Partners, and The Green Organic Dutchman Holdings.

      Rob Cheney, the CEO of C21 Investments, will be giving a keynote presentation about his company's strategy to become a regional cannabis powerhouse in the United States through a disciplined approach to acquisition and growth.

      Mr. Cheney will be followed by Randy Torcom, C21 Investments' VP of Marketing, who will speak about the company's goal to create compelling brands and deliver high-quality cannabis products that connect with consumers.

      Sky Pinnick, CEO of Phantom Farms (which C21 has an agreement to acquire), will talk about the company's vertically integrated business model which includes 125,000 square feet of canopy, an extraction lab and a distribution company.

      And Christine Smith, CEO of Grön Chocolate and Confections (which C21 has an agreement to acquire), will talk about how she has combined her project management experience, her culinary passion, and her creative background in the cannabis industry.

      "Our convention will benefit from the many different experts C21 is making available to participants," said Michael Kraland, Chairman of the Cannabis Capital Convention. "Having recently listed on the Frankfurt Stock Exchange, C21 Investments is of interest to investors attending our convention."

      Mr. Cheney said the C21 team is pleased to have four speakers participating in the conference, which he credits to the interest that European investors have in Canadian cannabis stocks in general, and the C21 Investments story in particular.

      ABOUT C21 INVESTMENTS
      C21 Investments Inc. (CSE: CXXI; FSE: C6QP) is a U.S. focused vertically integrated cannabis corporation that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. C21's current and announced operations currently comprise Silver State Relief in Nevada, as well as Phantom Farms, Swell Companies, Eco Firma Farms, and Grön Chocolate and Grön Confections in Oregon, and five dispensaries in two states. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. Based in Vancouver, Canada, C21 can be found at www.cxxi.ca.

      The CSE has not accepted responsibility for the adequacy or accuracy of this release.

      SOURCE C21 Investments Inc.

      For further information: Media contact: David Moorcroft, S2C Inc., david@strategy2communications.com, +1 416 727-1858; Investor contact: Keturah Nathe, Director, C21 Investments, knathe@cxxi.ca, +1 604 718-2800 # 312

      Robert Cheney (C21) - Tips for operating in different markets


      Sky Pinnick (Phantom Farms) - Market consolidation will happen


      Christine Smith (Grön Chocolate) - Working with consumer products


      Eric Shoemaker (Swell Companies) - Why this disruptive market has potential


      ---

      Cannabis Capital Convention: The Aftermovie

      https://cannabiscapitalconvention.eu/

      Gruß phobieeee
      Avatar
      schrieb am 23.10.18 18:48:28
      Beitrag Nr. 16 ()
      C21 Investments (CXXI.C) and the arms race in US Cannabis
      https://equity.guru/2018/10/22/u-s-cannabis-companies-buildi…

      Gruß phobieeee
      Avatar
      schrieb am 02.11.18 23:23:02
      Beitrag Nr. 17 ()
      Update on C21 Investments' acquisitions in Oregon
      Vancouver, British Columbia--(Newsfile Corp. - November 1, 2018) - C21 Investments Inc. (CSE: CXXI) (FSE: C6QP) today announced that it has entered into definitive agreements for the June 28, 2018 announced acquisition of 100% of Megawood Enterprises Inc. ("Pure Green"), which is the owner of the Pure Green Dispensary in Portland, Oregon. Pure Green is a 3,000 square foot retail dispensary and has been operating since January 2014 as a local retailer for both medical and recreational products.

      "The co-founders of Pure Green, Meghan and Matt Walstatter, will continue to work with the C21 team on the expansion of the company's retail network throughout Oregon," said Robert Cheney, President & CEO, C21 Investments. "Pure Green has an enviable reputation and we want to replicate its success throughout our operations."

      "We've seen a lot of changes in the cannabis industry and Matt and I believe joining the C21 Investments team will elevate our brand and further our capabilities," said Meghan Walstatter. "We want to continue to provide Oregon's medical patients and recreational customers with affordable, quality cannabis. The resources of C21 Investments will allow us to bring our community-oriented approach to customer service and strong emphasis on product knowledge to an ever-expanding audience."

      "Pure Green understands the Oregon canna-businesses, and we knew it was time to become part of something larger and C21 Investments is the perfect fit," said Matt Walsatter. "We're impressed by the dynamic combination of brands and personalities that comprise the C21 Investments family."

      Terms of Pure Green Acquisition

      The Pure Green acquisition is subject to prior approval of the Oregon Liquor Control Commission ("OLCC") which is expected to be received in approximately three months, with closing to occur following receipt of approval.

      C21 will acquire 100% of Pure Green, inclusive of all its brands and the retail location at 3738 NE Sandy Blvd, Portland, Oregon. The purchase price for Pure Green is USD$825,000, payable in cash and a non-interest bearing convertible promissory note. The vendors can elect to receive up to USD$650,000 in cash upon closing. The balance of the price will be paid by issuance of a non-interest-bearing Convertible Note which will be convertible into common shares of C21 calculated at a value of US$5.00 per common share.

      C21 Investments' strategy is to acquire existing and successful cannabis operations with experienced management teams in place. C21 Investments' focus is to expand into jurisdictions where it can wholly own indoor/outdoor cultivation operations, processing/extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.

      About Pure Green

      Pure Green is one of Portland's original licensed cannabis retailers and was founded by Matt and Meghan Walstatter, who have been public policy advocates for legalized cannabis for the past two decades. The dispensary is located in the Hollywood Neighbourhood, on Portland's "Green Mile" and in a building that once housed Portland's first post-prohibition liquor store.

      Grön Chocolate Update

      C21 Investments and Grön Chocolate, LLC and Grön Confections, LLC have mutually agreed not to proceed with the transaction announced August 13th, 2018. C21 Investments is in discussions with parties for manufacturing and branding opportunities globally for processed edible CBD and THC products. Potential partners with a scalable international presence in branded consumer goods will become the C21 Investments focus in the near term.

      ABOUT C21 INVESTMENTS

      C21 Investments Inc. (CSE: CXXI) (FSE: C6QP) is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The company owns Eco Firma Farms in Oregon, and has definitive agreements in place to acquire Silver State Relief and Silver State Cultivation in Nevada, Phantom Farms and Pure Green in Oregon, and Letters of intent to acquire Swell Companies, and two dispensaries in Oregon, all of which are expected to close this fiscal year (year-end January 31, 2019). These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. C21 Investments is also in active discussions to acquire additional operations in the USA and globally that will add to the company's ability to compete aggressively in the rapid growth of the cannabis industry and to grow revenue and EBITDA. Based in Vancouver, Canada, C21 can be found at www.cxxi.ca.

      Media contact:
      Graeme Harris
      S2C Inc.
      graeme@strategy2communications.com
      +1 416 402-7050

      Investor contact:
      Keturah Nathe
      Director, C21 Investments
      knathe@cxxi.ca
      +1 604 718-2800 # 312
      Avatar
      schrieb am 02.11.18 23:24:00
      Beitrag Nr. 18 ()
      Revision from Source - C21 Investments enters into definitive agreement for the acquisition of Swell Companies Limited

      A leading cannabis extraction and consumer packaged goods manufacturing
      company in Oregon

      VANCOUVER, Nov. 2, 2018 /CNW/ - C21 Investments Inc. (CSE: CXXI) (FSE: C6QP) today announced that it has entered into definitive agreements for the July 9, 2018 announced acquisition of Swell Companies Limited ("Swell"). Swell is an extraction, manufacturer and distributor of THC and CBD products. Swell has more than 50 of its branded products available in over 275 licensed retail locations across Oregon. Raw oil, encapsulates and vaporizers are distributed under its in-house brands: Dab Society Extracts and Hood Oil. The capacity of Swell's Portland processing facility will reach up to 5,000 lbs of raw material throughput a month. This throughput will translate into 220,000 to 270,000 grams of processed high-quality oil-based extracts per month, making Swell one of the largest processing groups in Oregon. Additionally, a new state of the art facility located in Bend, Oregon, will be operational in December adding a further capacity to process 1,200 lbs of raw material per month delivering a further 65,000 grams of processed high-quality extracts monthly.

      "Swell is C21 Investment's 4th US operation within its asset portfolio to sign a definitive agreement," said Robert Cheney, President and CEO of C21 Investments. "Acquiring Swell fulfills a critical segment in the Company's expansion strategy making C21 Investments a leading force in processing and manufacturing in the United States.

      "Consumption of cannabis concentrates, such as vapes and edibles, saw a 49%1 increase in 2018," said Alleh Lindquist, CEO of Swell. "This segment is quickly becoming the most significant component in cannabis consumption and with the support of C21, Swell will have the necessary resources to further expand its extraction and manufacturing capabilities to new markets

      Terms of Swell Companies Acquisition
      Upon receipt of approval of the Oregon Liquor Control Commission, and satisfaction of other customary closing conditions, C21 Investments is to acquire all of the outstanding shares in the capital stock of Swell. The aggregate purchase price payable is (1) US$500,000 payable in cash on closing; plus (2) US$4,150,000 minus certain pre-closing liabilities of Swell, payable by the issue of common shares of C21 ("C21 shares") on closing at a deemed issue price of USD$3.00 per share, plus (3) US$ 3,200,000 minus certain assumed indebtedness of Swell, payable by the issue of C21 shares at a deemed issue price of USD$3.00 per share, plus (4) warrants to purchase 1,580,000 C21 shares at an exercise price of CA$1.50 per share, plus (5) up to an additional 6,000,000 C21 shares upon C21's business achieving certain performance targets over up to a 5-year period following the closing date, at a deemed issue price of US3.00 per share.

      About Swell Companies
      Swell has a 10,000-square foot facility in Portland, Oregon and has expansion rights for an additional 18,000 square feet, adjacent to the primary facility. It also operates a 5,000-square foot distribution warehouse. Swell currently employs 30 full-time industry professionals and prides itself on being one of the first cannabis companies in Oregon to offer comprehensive benefits to all its employees.

      Operating since 2015, Swell has been recognized as a leader in the extraction and manufacturing of THC and CBD derived products; always demonstrating a commitment to quality, consistent innovation, and execution at scale. In 2017, Swell shipped over 500,000 product units within Oregon and has more than doubled its product units shipped through existing sales channels in 2018.

      www.be-swell.com

      ABOUT C21 INVESTMENTS
      C21 Investments Inc. (CSE: CXXI) (FSE: C6QP) is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The company owns Eco Firma Farms in Oregon, and has definitive agreements in place that are expected to close prior to the Companies year end of Jan 31, 2019 to acquire Silver State Relief and Silver State Cultivation in Nevada and Phantom Farms and Swell in Oregon, and Letters of intent to acquire and expected to also close prior to year-end with three dispensaries in Oregon. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. C21 Investments is also in active discussions to acquire additional operations in the USA and globally that will add to the company's ability to compete aggressively in the rapid growth of the cannabis industry and to grow revenue and EBITDA. Based in Vancouver, Canada, C21 can be found at www.cxxi.ca.
      Avatar
      schrieb am 02.11.18 23:25:12
      Beitrag Nr. 19 ()
      C21 Investments is being featured on BNN Bloomberg on Nov. 3 - Nov. 4, 2018 Monday through Friday, throughout the day and evenings.

      Avatar
      schrieb am 06.11.18 22:14:08
      Beitrag Nr. 20 ()


      Schöne Bewegung heute aber noch zu früh um von einer Trendwende zu sprechen.

      Gruß phobieeee
      Avatar
      schrieb am 06.11.18 22:17:46
      Beitrag Nr. 21 ()
      C21 Investments granted first CBD licence issued in Ukraine
      Five-Year licence allows importation, processing, wholesale distribution and re-export of a range of CBD extracts, concentrates and finished products

      VANCOUVER, Nov. 6, 2018 /CNW/ - C21 Investments Inc. (CSE: CXXI) (FSE: C6QP) today announced that it has been granted the first licence issued by the State Service of Ukraine on Medicines and Drugs Control ("SSUMDC") for the importation of high-quality raw CBD extracts and concentrates, to import finished CBD products, to conduct CBD processing, wholesale distribution of CBD and CBD finished products, and to re-export CBD concentrates and CBD processed products to Europe and internationally.

      C21 Investments has opened a representative office in Kyiv, Ukraine (CNW Group/C21 Investments Inc.)

      According to Robert Cheney, C21 Investments' Chief Executive Officer, the granting of this first Ukraine CBD licence issued by SSUMDC is a testament to the quality of C21's products, its quality control systems, and its internal compliance processes as well as the high regard of the Ukrainian Government for the integrity of the C21 management team.

      "We at C21 are excited to receive the first licence issued in the Ukraine and to expand into Europe," said Mr. Cheney. "This is a significant opportunity for us to build a new industry, create new high-quality jobs and to leverage the competitive advantages of Ukraine to access the EU and global markets. Building on a solid relationship with the Ukrainian Government and the staff of SSUMDC, the C21 team is in the process of applying for additional licences, including for the cultivation of both hemp and cannabis.

      Ukraine has a population of over 42 million people and is a major trading partner with the European Union. In 2014, Ukraine signed an agreement referred to as the "Association Agreement" making trade with the EU much easier. Trade with the EU has increased significantly as a result. Ukraine offers a long history in agriculture, a skilled labour pool, attractive wage rates, and preferential access to European markets.

      CBD extracts and products with minimal THC content are legal in multiple countries within the European Union. C21 will now have the ability to distribute and market its branded products across much of the EU targeting a large portion of a market with 742 million consumers.

      C21 Investments has opened a representative office in Kyiv, the capital of Ukraine, in order to oversee its operations as well as pursue other business development opportunities across Europe.

      ABOUT C21 INVESTMENTS

      C21 Investments Inc. (CSE: CXXI) (FSE: C6QP) is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The company owns Eco Firma Farms in Oregon, and has definitive agreements in place that are expected to close prior to the Company's year end of January 31, 2019 to acquire Silver State Relief and Silver State Cultivation in Nevada and Phantom Farms, Pure Green and Swell in Oregon, and Letters of Intent to acquire and expected to also close prior to year-end with two dispensaries in Oregon. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. C21 Investments is also in active discussions to acquire additional operations in the USA and globally that will add to the company's ability to compete aggressively in the rapid growth of the cannabis industry and to grow revenue and EBITDA. Based in Vancouver, Canada, C21 can be found at www.cxxi.ca.

      Cautionary Statement:
      Disclaimer: This press release contains "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the Company's future business operation, expectations of gross sales, the opinions or beliefs of management and future business goals, statements regarding the timing and completion of the listing on the CSE and C21's USA Acquisitions. Generally, forward looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to general business, economic and competitive uncertainties, regulatory risks including risks related to the expected timing of the Company's participation in the Adult Use market, market risks, risks inherent in manufacturing operations and other risks of the cannabis industry. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking information. Forward-looking information is provided herein for the purpose of presenting information about management's current expectations relating to the future and readers are cautioned that such information may not be appropriate for other purpose. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws. This Release does not constitute an offer of securities for sale in the United States, and such securities may not be offered or sold in the United States absent registration or an exemption from registration or an exemption from registration.

      The CSE has not accepted responsibility for the adequacy or accuracy of this release.
      Avatar
      schrieb am 07.11.18 20:36:38
      Beitrag Nr. 22 ()
      C21 Investments | What We've Been Up To
      https://cxxi.us18.list-manage.com/track/click?u=f4e64c146250…
      Avatar
      schrieb am 08.11.18 19:42:34
      Beitrag Nr. 23 ()
      C21 Investments Announces Private Placement of up to $45 Million of Convertible Debentures
      /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE U.S./

      VANCOUVER, Nov. 8, 2018 /CNW/ - C21 Investments Inc. ("C21" or the "Company") (CSE: CXXI) (FSE: C6QP) today announced that it has entered into a brokered syndicated private placement led by Industrial Alliance Securities Inc. (the "Lead Agent") with Canaccord Genuity Corp. and Sprott Capital Partners joining as syndicate members (collectively with the Lead Agent, the "Agents") for the sale of up to 45,000 units of C21 (the "Units"), at a price of $1,000 per Unit, for gross proceeds of a minimum of $20,000,000 and up to a maximum of $45,000,000 (the "Offering").

      C21 Investments announces private placement (CNW Group/C21 Investments Inc.)

      In addition, C21 has granted the Agents an over-allotment option, exercisable in whole or in part, at the discretion of the Agents, to arrange for the purchase of up to an additional 15% of the Units sold by the Agents, at any time until the closing of the Offering.

      Each Unit consists of one $1,000 principal amount 10% unsecured convertible debenture (the "Debenture") and one-half of one non-transferable debenture warrant (each whole warrant, a "Warrant"). Each Warrant will entitle the holder thereof to purchase, for a period of 24 months from the date of issue, one additional $1,000 principal amount 10% unsecured convertible debenture (a "Warrant Debenture") at an exercise price of $1,000 per Warrant Debenture. The Debentures are convertible to common shares of C21 at a price of $1.50 per common share. The Warrant Debentures are convertible into common shares of C21 at a price of $2.25 per common share. The Debentures and Warrant Debentures will mature two years from the date of issuance of the Debentures.

      "This additional capital will accelerate our growth and expansion plans in the United States and globally," said Robert Cheney, Chief Executive Officer of C21. "It is exciting to participate in an industry growing as rapidly as ours and with a regulatory landscape that continues to improve."

      Net proceeds from the Offering are intended to be used primarily to complete previously announced acquisitions in the United States, and to upgrade and expand the acquired businesses.

      In consideration of the services rendered by the Agents in connection with the Offering, C21 has agreed to pay the Agents on the closing of the Offering an aggregate cash fee equal to: (a) 6.0% of the gross proceeds of the Offering resulting from the sale of Units to purchasers (other than purchasers identified on a mutually agreed upon subscriber list (the "President's List")); and (b) 3% of the gross proceeds of the Offering resulting from the sale of Units to purchasers on the President's List. In addition, C21 has agreed to issue to the Agents warrants for the purchase of Debentures in a number equal to: (a) 6% of the number of Units sold to purchasers (other than to purchasers on the President's List); and (b) 3% of the number of Units sold to purchases on the President's List.

      Closing of the Offering is expected to occur November 28, 2018 and is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including the Canadian Securities Exchange (the "CSE").

      This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities in the United States, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws, and, accordingly, may not be offered or sold within the United States, or to or for the account or benefit of persons in the United States or "U.S. Persons", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

      ABOUT C21 INVESTMENTS
      C21 Investments Inc. (CSE: CXXI) (FSE: C6QP) is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company owns Eco Firma Farms in Oregon, and has definitive agreements in place that are expected to close prior to the Company's year end of January 31, 2019 to acquire Silver State Relief and Silver State Cultivation in Nevada and Phantom Farms, Pure Green and Swell in Oregon, and Letters of Intent to acquire and expected to also close prior to year-end with two dispensaries in Oregon. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. C21 is also in active discussions to acquire additional operations in the USA and globally, which includes the first CBD license issued in Ukraine. These developments will add to the Company's ability to compete aggressively in the rapid growth of the cannabis industry and to grow revenue and EBITDA. Based in Vancouver, Canada, additional information on C21 can be found at www.sedar.com and www.cxxi.ca.

      Cautionary Statement:

      Certain statements contained in this news release may constitute forward-looking statements within the meaning of applicable securities legislation. Forward-looking statements are often, but not always, identified by the use of words such as "anticipate", "plan", "expect", "may", "will", "intend", "should", and similar expressions. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Forward looking statements in this news release include: (i) net proceeds from the Offering are intended to be used primarily to complete previously announced acquisitions in the United States, and to upgrade and expand the acquired businesses; and (ii) closing of the Offering is expected to occur on November 28, 2018, and is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including the Canadian Securities Exchange; (iii) the Company owns Eco Firma Farms in Oregon, and has definitive agreements in place that are expected to close prior to the Company's year end of January 31, 2019 to acquire Silver State Relief and Silver State Cultivation in Nevada and Phantom Farms, Pure Green and Swell in Oregon, and Letters of Intent to acquire and expected to also close prior to year-end with two dispensaries in Oregon .

      The forward-looking statements contained in this news release are based on certain key expectations and assumptions made by C21. Although C21 believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because C21 can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the failure to obtain necessary regulatory approvals or satisfy the conditions to closing the Offering, C21's inability to complete previously announced acquisitions or, if completed, to upgrade and expand the acquired business as planned, competitive factors in the industries in which C21 operates, prevailing economic and regulatory conditions, and other factors, many of which are beyond the control of C21.

      The forward-looking statements contained in this news release represent C21's expectations as of the date hereof, and are subject to change after such date. C21 disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required under applicable securities regulations.

      The CSE has not accepted responsibility for the adequacy or accuracy of this release.

      SOURCE C21 Investments Inc.
      Avatar
      schrieb am 10.11.18 13:30:51
      Beitrag Nr. 24 ()
      Avatar
      schrieb am 10.11.18 13:51:01
      Beitrag Nr. 25 ()
      The US and Canada are in a Race for Marijuana Branding Dominance – The US is Winning

      https://grizzle.com/race-for-marijuana-branding-dominance-u-…
      Avatar
      schrieb am 01.12.18 18:41:54
      Beitrag Nr. 26 ()
      Large Revenue Projection for 2019 - C21 Investments
      Avatar
      schrieb am 03.12.18 21:55:03
      Beitrag Nr. 27 ()
      Absolut enttäuschend die jüngste Entwicklung.

      Zu viel Euphorie und Aussagen seitens Management, die sich dann bis jetzt noch nicht bewahrheitet haben. Insbesondere das US Listing lässt sich doch sehr lange auf sich warten und auch wenn man tatsächlich von Behörden abhängig ist, so wurden hier Aussagen getätigt von denen man sich rückblickend sicher gerne distanziert hätte.

      Es bleibt abzuwarten, ob das Placement in der angedachten Form geschlossen wird und welche Deals final unterzeichnet werden. Sicherliche ist insbesondere für den heutigen Rückgang auch das allgemeine Marktumfeld nicht förderlich, aber mehr und mehr verlieren die Geduld.

      Ich bin aktuell nicht mutig genug hier nachzukaufen... Management muss erst wieder liefern.



      Gruß phobieeee
      2 Antworten
      Avatar
      schrieb am 05.12.18 21:12:59
      Beitrag Nr. 28 ()
      Harvest Season: Life on a Cannabis Farm in Southern Oregon
      Avatar
      schrieb am 05.12.18 22:22:15
      Beitrag Nr. 29 ()
      Avatar
      schrieb am 05.12.18 22:25:39
      Beitrag Nr. 30 ()
      Avatar
      schrieb am 06.12.18 09:19:21
      Beitrag Nr. 31 ()
      Bruce Campbell erwähnt im Interview vom 5. Dezember 2018 "C21 Investments"

      https://aktien-boersen.blogspot.com/2018/12/cannabis-aktien-…
      Avatar
      schrieb am 12.12.18 21:55:14
      Beitrag Nr. 32 ()
      Antwort auf Beitrag Nr.: 59.354.345 von phobieeee am 03.12.18 21:55:03Hätte ich mal... schöne Bewegung die letzten Tage, wäre ein schöner Zwischengewinn gewesen.





      Offiziell jedoch nichts neues, ein paar Gerüchte kursieren.

      Gruß phobieeeee
      1 Antwort
      Avatar
      schrieb am 12.12.18 23:11:03
      Beitrag Nr. 33 ()
      Antwort auf Beitrag Nr.: 59.427.546 von phobieeee am 12.12.18 21:55:14
      C21 Investments Announces Restructured Acquisition of Silver State Relief
      Jetzt offiziell...

      https://ceo.ca/@newswire/c21-investments-announces-restructu…[/url]
      Avatar
      schrieb am 14.12.18 22:37:32
      Beitrag Nr. 34 ()
      C21 Investments Amends Previously Announced Private Placement of Convertible Debentures
      https://ceo.ca/@newswire/c21-investments-amends-previously-a…
      Avatar
      schrieb am 14.12.18 22:39:20
      Beitrag Nr. 35 ()
      C21 Investments Inc.: Clarification of Ukraine License and Operations
      https://ceo.ca/@newsfile/c21-investments-inc-clarification-o…
      Avatar
      schrieb am 29.12.18 09:51:21
      Beitrag Nr. 36 ()
      C21 Investments Announces Alignment of Management of Oregon Operations, Termination of Discussions with 7 Leaf Dispensary and Restructuring of Eco Firma Farms Real Estate Rights

      https://ceo.ca/@newsfile/c21-investments-announces-alignment…

      Leider nicht die gewünschte Entwicklung aktuell. Nach Grön Chocolate der nächste Deal der nicht geschlossen wird.

      Gruß phobieeee
      Avatar
      schrieb am 01.01.19 20:37:54
      Beitrag Nr. 37 ()
      C21 Investments Closes First Tranche of Private Placement Financing
      https://ceo.ca/@newswire/c21-investments-closes-first-tranch…
      Avatar
      schrieb am 09.01.19 20:58:35
      Beitrag Nr. 38 ()
      Avatar
      schrieb am 09.01.19 21:00:35
      Beitrag Nr. 39 ()
      Status Update zum OTC Listing.

      "Yes, we are still in the process of getting our US listing. There aren't problems, just quite a few steps to the process. In order to obtain an OTC listing, C21 needs both the SEC’s and FINRA’s approval.

      The SEC approved C21’s listing on September 12th. But unfortunately the FINRA approval has been held up and has taken quite some time, with the latest delay being the US government shut down.

      We are optimistic and expect this to be resolved in a relatively short period of time, once FINRA is resolved."

      Gruß phobieeee
      Avatar
      schrieb am 10.01.19 22:51:51
      Beitrag Nr. 40 ()
      C21 Investments Receives Regulatory Approval for Transfer of Silver State Nevada Licenses
      https://ceo.ca/@newswire/c21-investments-receives-regulatory…[/url]
      Avatar
      schrieb am 16.01.19 19:26:10
      Beitrag Nr. 41 ()
      C21 Investments Receives Regulatory Approval for Transfer of Phantom Farms' Oregon Licenses
      https://ceo.ca/@newswire/c21-investments-receives-regulatory…
      Avatar
      schrieb am 18.01.19 22:17:41
      Beitrag Nr. 42 ()
      C21 Investments Opens Second Nevada Dispensary
      https://ceo.ca/@newswire/c21-investments-opens-second-nevada…

      "VANCOUVER, Jan. 18, 2019 /CNW/ - C21 Investments Inc. (CSE: CXXI) today announced that it has opened a 6,000 square foot dispensary located in Fernley, Nevada. The Fernley dispensary is located in an area experiencing rapid economic growth with housing and business development and there are no other licensed dispensary operations within a 50-kilometer radius.

      C21 Investments' Silver State Relief dispensary in Fernley, Nevada opened on January 17, 2019 (CNW Group/C21 Investments Inc.)..."
      Avatar
      schrieb am 20.01.19 14:11:21
      Beitrag Nr. 43 ()
      Schon etwas älter...





      Gruß phobieeee
      Avatar
      schrieb am 20.01.19 22:14:50
      Beitrag Nr. 44 ()
      Avatar
      schrieb am 24.01.19 22:15:59
      Beitrag Nr. 45 ()
      FTMIG Breaks Down the TA With Johnny Mac | C21 INVESTMENTS : CXXI.CN


      Gruß phobieeee
      Avatar
      schrieb am 25.01.19 20:04:45
      Beitrag Nr. 46 ()
      C21 Investments completes acquisition of Pure Green Dispensary
      https://ceo.ca/@newswire/c21-investments-completes-acquisiti…
      Avatar
      schrieb am 25.01.19 22:53:11
      Beitrag Nr. 47 ()
      C21 Investments Announces Increase to Previously Announced Private Placement to $15 Million
      https://ceo.ca/@newswire/c21-investments-announces-increase-…[/url]

      Gruß phobieeee
      1 Antwort
      Avatar
      schrieb am 30.01.19 19:59:20
      Beitrag Nr. 48 ()
      Antwort auf Beitrag Nr.: 59.715.243 von phobieeee am 25.01.19 22:53:11
      C21 Investments Closes Final Tranche of Upsized Private Placement
      https://ceo.ca/@newswire/c21-investments-closes-final-tranch…
      Avatar
      schrieb am 03.02.19 19:41:01
      Beitrag Nr. 49 ()
      Avatar
      schrieb am 04.02.19 22:22:06
      Beitrag Nr. 50 ()
      C21 Investments completes acquisition of Phantom Farms
      https://ceo.ca/@newswire/c21-investments-completes-acquisiti…[/url]
      Avatar
      schrieb am 15.02.19 22:59:40
      Beitrag Nr. 51 ()
      Avatar
      schrieb am 15.02.19 23:00:59
      Beitrag Nr. 52 ()
      The Cannabis Revolution Explained | C21 Investments


      From seed to stem to science to sale, C21 Investments is leading the revolution in the world of consumer branded cannabis products.

      C21 is a collection of pioneers, builders, and dreamers dedicated to growing brands and maximizing potential in the consumer and retail cannabis industry.

      Gruß phobieeee
      Avatar
      schrieb am 16.02.19 18:03:46
      Beitrag Nr. 53 ()
      C21 Investments Inc. (CNSX:CXX1) CEO, Robert Cheney
      Avatar
      schrieb am 26.02.19 21:12:51
      Beitrag Nr. 54 ()
      Avatar
      schrieb am 27.02.19 07:29:07
      Beitrag Nr. 55 ()
      Ich wollte gestern hier einsteigen, jedoch musste ich feststellen, dass bei onvista diese Aktie aktuell nicht Handelbar ist.
      Hat da einer von euch auch schon Erfahurngen?
      Ich habe Onvista hierzu angeschrieben.

      @Phobieeee: Dnake für deinen tollen Ratschläge - macht Spaß dir zu "folgen"
      1 Antwort
      Avatar
      schrieb am 27.02.19 07:56:55
      Beitrag Nr. 56 ()
      Antwort auf Beitrag Nr.: 59.972.509 von lukech am 27.02.19 07:29:07Hallo @lukech Handel in Deutschland geht seit einiger Zeit schon nicht mehr, aber bei vielen kanadischen Werten bietet es sich auch an direkt in Kanada zu handelt. Gerade bei wenig bekannten Werten ist der Handel in DE gering und der Spread enorm.

      Nichts desto trotz bleibt die Firma eine Antwort schuldig.

      https://twitter.com/phobieeee_/status/1099646013617463296?s=…[/url]

      Gruß phobieeee
      Avatar
      schrieb am 04.03.19 21:05:55
      Beitrag Nr. 57 ()
      Erhält hier immer noch wenig Beachtung, in den einschlägigen sozialen Medien dafür zuletzt immer mehr entdeckt worden.



      "C21 Investments #CXXI CEO Robert Cheney is conducting a 2nd interview on Midas Letter Live today, as the first was a smashing success. It will be airing at 3:30 EST today. Please visit http://www.midasletter.com to stream the broadcast, or visit our YouTube channel directly. Enjoy!"

      Gruß phobieeee
      Avatar
      schrieb am 04.03.19 21:15:29
      Beitrag Nr. 58 ()
      1 Antwort
      Avatar
      schrieb am 05.03.19 21:14:20
      Beitrag Nr. 59 ()
      Antwort auf Beitrag Nr.: 60.018.779 von phobieeee am 04.03.19 21:15:29

      Gruß phobieeee
      Avatar
      schrieb am 05.03.19 22:43:45
      Beitrag Nr. 60 ()
      Cheney ist jetzt nicht ganz so der große Macker :D aber ich mag CXXI total

      lange drauf gewartet und jetzt macht das richtig Spaß :-))))
      3 Antworten
      Avatar
      schrieb am 06.03.19 23:16:27
      Beitrag Nr. 61 ()
      Antwort auf Beitrag Nr.: 60.028.787 von DRS75 am 05.03.19 22:43:45Hallo @DRS75 ich habe großes Vertrauen in Rob und seine Fähigkeiten mit C21 Investment etwas großes aufzubauen mit suggesivem Wachstum und einem Team welches die gleichen Ziele im längerfristigen Kontext verfolgt. Das soll nicht bedeuten, dass es keine Herausforderungen gibt oder es ein Selbstgänger wird, aber die grundsätzliche Herangehensweise spricht mich persönlich an. Ich verfolge CXXI wie man hier sehen kann schon seit Anfang an (auch wenn mir wer mit der Threaderöffnung zuvor gekommen ist) nur wie so oft das Timing nicht ganz optimal gewählt gehabt.

      Ich sehe es aktuelle als Bildung einer soliden Basis für weitere Aquisitionen und Positionierung im US Markt für das was aller Wahrscheinlichkeit kommen wird. Branding und vertikale Integration - d.h. von Anbau, Verarbeitung und Vertrieb - sind integrale Punkte.

      Im Moment erhält mir CXXI etwas zu viel Aufmerksamkeit und eine Abkühlung wäre meiner Meinung nach wünschenswert und würde ich auch nicht ausschließen. Mit tatsächlichem US Listing sehe ich hier einen weiteren Schub und Volumensteigerungen. Es gibt den einen oder anderen US Investor der gerne einsteigen würde aber nicht an der CSE handeln darf/kann/will...

      Mal sehen wann hier mehr Leute in den Thread finden. Um meine Village Farms war es auch lange ruhig. ;)

      Gruß phobieeee
      2 Antworten
      Avatar
      schrieb am 07.03.19 22:41:14
      Beitrag Nr. 62 ()
      sehe ich ähnlich

      von mir aus auch noch mal runter auf 1.50-1.60 CAD - dann werden das lockere 100% bis zum Jahresende m M n
      Avatar
      schrieb am 07.03.19 22:44:40
      Beitrag Nr. 63 ()
      C21 Investments Advises No Longer Trading on Frankfurt Exchange
      Vancouver, British Columbia--(Newsfile Corp. - March 7, 2019) - C21 Investments Inc. (CSE: CXXI) wishes to advise that as a result of policy changes of the Frankfurt Exchange, the common shares of the Company ceased trading and were delisted from the Frankfurt Exchange under symbol "C6QP" on October 31, 2018. The shares were listed without Company involvement for a very short period of time, and no material number of shares traded on the Frankfurt Exchange.

      https://ceo.ca/@newsfile/c21-investments-advises-no-longer-t…
      Avatar
      schrieb am 09.03.19 01:48:36
      Beitrag Nr. 64 ()

      http://midasletter.com/2019/03/c21-investments-inc-cnsxcxxi-…
      Avatar
      schrieb am 09.03.19 02:01:53
      Beitrag Nr. 65 ()
      Antwort auf Beitrag Nr.: 60.037.745 von phobieeee am 06.03.19 23:16:27Was ich Dir sagen kann: Die Leute interessieren sich weitestgehend nicht für "Eine Firma".


      Die interessiert ob Das Shiceding steigt, oder nicht.

      ENDE.
      Avatar
      schrieb am 11.03.19 20:51:48
      Beitrag Nr. 66 ()
      Antwort auf Beitrag Nr.: 60.037.745 von phobieeee am 06.03.19 23:16:27
      Zitat von phobieeee: Im Moment erhält mir CXXI etwas zu viel Aufmerksamkeit und eine Abkühlung wäre meiner Meinung nach wünschenswert und würde ich auch nicht ausschließen.


      Manchmal sollte man auf sein Bauchgefühl hören uznd auch danach handeln. Es wird gemutmaßt, dass ein offenes GAP bei 1.25 CAD jetzt noch geschlossen wird. Selbsterfüllende Prophezeiung? Wir werden es sehen.



      Gruß phobieeee
      Avatar
      schrieb am 11.03.19 21:25:06
      Beitrag Nr. 67 ()
      Wird geschlossen. Darauf würde ich sogar wetten.

      1 Antwort
      Avatar
      schrieb am 18.03.19 21:07:24
      Beitrag Nr. 68 ()
      Antwort auf Beitrag Nr.: 60.073.449 von sir_krisowaritschko am 11.03.19 21:25:06Moin moin,

      würdest du immer noch darauf wetten? Hier in DE interessiert sich wieder mal keiner für den Wert.
      Ich würde fast wetten, dass wir das GAP nicht mehr schließen werden.



      Gruß phobieeee
      Avatar
      schrieb am 18.03.19 21:13:30
      Beitrag Nr. 69 ()
      Ja, aber Nagel mich nicht auf einen Zeitraum fest. Kann auch noch ein halbes Jahr dauern. Möglichweise zwischenzeitlich neues hoch um dann zum Gap durchzukonsolidieren.
      2 Antworten
      Avatar
      schrieb am 18.03.19 21:52:23
      Beitrag Nr. 70 ()
      Falls sich wer fragt warum der Kurs heute unter erhöhtem Volumen angesteigen ist.
      Jonathan Goldsmith @JonthanGolds (Twitter) hat heute am Markt 525.000 CXXI Aktien gekauft zu einem Durchschnittskurs von CAD 1.71. Er hat eine kleine Gefolgschaft und einen guten Track Record. Große Positionen um CAD 1 Million sind keine Seltenheit. Ein Dickfisch sozusagen. Nach eigener Aussage möchte er wohl insgesamt 1 Million Stücke erwerben.

      https://twitter.com/JonthanGolds/status/1107738998796177410

      Dies zur Info.

      Gruß phobieeee
      Avatar
      schrieb am 19.03.19 22:43:47
      Beitrag Nr. 71 ()
      jau, möchte mittelfristig auch im Board sitzen usw. #whale
      Avatar
      schrieb am 19.03.19 22:44:52
      Beitrag Nr. 72 ()
      jau, möchte mittelfristig auch im Board sitzen usw. #whale

      man kann, wenn man möchte, auch nach(ver)folgen wo er noch investiert
      (immer mit dem Risiko, dass man seinen Exit nicht mitbekommt natürlich)
      Avatar
      schrieb am 25.03.19 21:34:24
      Beitrag Nr. 73 ()
      Das war ja Mal ein starker Schluss😎
      1 Antwort
      Avatar
      schrieb am 25.03.19 21:54:48
      Beitrag Nr. 74 ()
      Antwort auf Beitrag Nr.: 60.192.695 von HeinzBork am 25.03.19 21:34:24Ja definitiv ein schöner Move zum Handelsende, aber auch insgesamt seit Januar.
      Bleibt nur noch das US Listing was sich ja seit geraumer Zeit hinzieht.





      Gruß phobieeee
      Avatar
      schrieb am 26.03.19 22:26:17
      Beitrag Nr. 75 ()
      BREAKING: WARREN BUFFETT Of Cannabis Reveals Blue-Chip MANIA - Robert Cheney EXCLUSIVE!



      PortfolioWealthGlobal.com/C21



      Legal Notice: This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.

      Never base any decision off of our advertorials. Portfolio Wealth Global stock profiles are intended to be stock ideas, NOT recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. Wallace Hill Partners LTD, a Canadian company, which is owned by the same individuals as Portfolio Wealth Global LLC, has been compensated three hunrdred thousands dollars, five hundred canandian dollars and one million, eight hundred thousand RSUs, directly by C21 investments for a three year marketing agreement. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say.

      Teurer Spaß diese Promotion... bin kein Freund davon und "semi-professioneller" Auftritt...

      Gruß phobieeee
      Avatar
      schrieb am 04.04.19 15:50:11
      Beitrag Nr. 76 ()
      C21 Investments announces unaudited revenue of US$5.1 million for first two months of 2020 fiscal year
      https://ceo.ca/@newswire/c21-investments-announces-unaudited…

      Gruß phobieeee
      Avatar
      schrieb am 04.04.19 20:46:19
      Beitrag Nr. 77 ()
      Bruce Campbell discusses C21 Investments
      Bruce Campbell, president of StoneCastle Investment Management, discusses C21 Investments.

      https://www.bnnbloomberg.ca/market-call/bruce-campbell-discu…

      Gruß phobieeee
      1 Antwort
      Avatar
      schrieb am 08.04.19 03:39:50
      Beitrag Nr. 78 ()
      Antwort auf Beitrag Nr.: 60.281.802 von phobieeee am 04.04.19 20:46:19Wööööörter Phobieeee ,

      Sie haben ja gerade, aaas it SEEEEEMS to be , Einen "Cannabis"Lauf.
      Wollen Sie Nochwas, for@Ansehen ??


      Dies ist Kein Allgemeinangebot, sondern gilt nur für Diese Person.
      Avatar
      schrieb am 20.04.19 12:45:43
      Beitrag Nr. 79 ()
      Bin auf diese Aktie gestoßen und die Rahmenbedingungen gefallen mir sehr gut.

      Aber bin ich jetzt zu doof um die aktuelle Präsentation auf der HP zu finden. Dein Link zeigt die "404" phobieee und ansonsten muss ich denen ne Mail schicken...?
      1 Antwort
      Avatar
      schrieb am 20.04.19 23:31:05
      Beitrag Nr. 80 ()
      Antwort auf Beitrag Nr.: 60.393.136 von ThatsIt35 am 20.04.19 12:45:43Aktuell auf der Homepage nicht abrufbar, es soll in Kürze eine aktualisierte Präsentation hochgeladen werden. Wann genau kann ich dir jedoch nicht sagen.

      Gruß phobieeee
      Avatar
      schrieb am 04.05.19 11:42:31
      Beitrag Nr. 81 ()
      OTC Markets Ticker ist jetzt seit Freitag bestätigt, offizielle News dann vermutlich am Montag.

      Gruß phobieeee
      Avatar
      schrieb am 04.05.19 11:46:43
      Beitrag Nr. 82 ()
      Phantom Farms introduces new Vape Pen for US$3 billion market
      https://ceo.ca/@newswire/phantom-farms-introduces-new-vape-p…
      Avatar
      schrieb am 20.05.19 10:05:07
      Beitrag Nr. 83 ()
      Antwort auf Beitrag Nr.: 60.133.959 von sir_krisowaritschko am 18.03.19 21:13:30
      Zitat von sir_krisowaritschko: Ja, aber Nagel mich nicht auf einen Zeitraum fest. Kann auch noch ein halbes Jahr dauern. Möglichweise zwischenzeitlich neues hoch um dann zum Gap durchzukonsolidieren.


      viel fehlt nich mehr.
      1 Antwort
      Avatar
      schrieb am 22.05.19 16:07:55
      Beitrag Nr. 84 ()
      Antwort auf Beitrag Nr.: 60.601.106 von sir_krisowaritschko am 20.05.19 10:05:07
      gapclose



      Avatar
      schrieb am 27.05.19 14:39:21
      Beitrag Nr. 85 ()
      C21 Investments completes acquisition of Swell Companies
      https://ceo.ca/@newswire/c21-investments-completes-acquisiti…
      Avatar
      schrieb am 01.07.19 21:24:04
      Beitrag Nr. 86 ()
      C21 Investments Announces Closing of Non-Brokered Private Placement for Proceeds of CDN$7.7 million
      https://ceo.ca/@newswire/c21-investments-announces-closing-o…

      C21 Investments Inc. Announces Issuance of Convertible Promissory Note
      https://ceo.ca/@newsfile/c21-investments-inc-announces-issua…

      C21 reports unaudited revenue of US$3.2 million for May 2019
      https://ceo.ca/@newswire/c21-reports-unaudited-revenue-of-us…

      C21 Investments launches B2B cannabis distribution company
      https://ceo.ca/@newswire/c21-investments-launches-b2b-cannab…
      C21 Investments | 0,860 $
      Avatar
      schrieb am 08.07.19 21:06:55
      Beitrag Nr. 87 ()
      C21 Investments Updates Status of Secured Debt and Forward Obligations
      https://ceo.ca/@newswire/c21-investments-updates-status-of-s…

      C21 Investments appoints Sonny Newman as CEO Robert Cheney to remain on Board of Directors
      https://ceo.ca/@newswire/c21-investments-appoints-sonny-newm…
      C21 Investments | 0,700 $
      Avatar
      schrieb am 17.09.19 11:15:23
      Beitrag Nr. 88 ()
      16-07-2019 C21 Investments releases letter to shareholders
      https://ceo.ca/@newswire/c21-investments-releases-letter-to-…

      30-07-2019 C21 Investments common shares eligible for DTC in the United States
      https://ceo.ca/@newswire/c21-investments-common-shares-eligi…

      08-08-2019 C21 Investments announces unaudited revenue of US$9.8 million for the second quarter of the 2020 fiscal year
      https://ceo.ca/@newswire/c21-investments-announces-unaudited…

      23-08-2019 C21 Investments Announces Upgrade to OTCQB Venture Market
      https://ceo.ca/@newsfile/c21-investments-announces-upgrade-t…

      04-09-2019 C21 Investments Announces Amendment to Forward-Cash Obligations to Vendors of Swell Companies
      https://ceo.ca/@newsfile/c21-investments-announces-amendment…

      11-09-2019 C21 Investments Engages CB1 Capital as Strategic Business Advisors
      https://ceo.ca/@newsfile/c21-investments-engages-cb1-capital…

      12-09-2019 C21 Investments Q2 Revenue Increases 27% to $9.86 Million
      https://ceo.ca/@newswire/c21-investments-q2-revenue-increase…

      Gruß phobieeee
      C21 Investments | 0,509 $
      Avatar
      schrieb am 13.05.20 14:56:36
      Beitrag Nr. 89 ()
      Keiner mehr hier investiert?
      C21 Investments | 0,380 $
      Avatar
      schrieb am 10.02.21 20:04:58
      Beitrag Nr. 90 ()
      Noch jemand hier investiert?
      C21 Investments | 1,940 $
      Avatar
      schrieb am 10.02.21 20:08:02
      Beitrag Nr. 91 ()
      Letzter Quartalsbericht:

      https://www.prnewswire.com/news-releases/c21-investments-ann…

      Auszug:

      - Revenue of $9.5 million – a record $8.9 million from Nevada's retail operations with same-store sales up 5% from Q2
      - Gross Profit of $5.9 million; Gross Margin (before fair value adjustments) of 47.4%
      - Adjusted EBITDA1 of $2.7 million, the seventh consecutive quarter of positive EBITDA
      - Cash Flow from Operations of $3.1 million; Year-to-Date results of $8.7 million, up 175% from last year
      - Net Income of $2.3 million

      Eines der wenigen Cannabis-Unternehmen was Gewinn erwirtschaftet und dann noch 7 Quartale in Folge.
      C21 Investments | 1,920 $
      Avatar
      schrieb am 11.02.21 22:25:31
      Beitrag Nr. 92 ()
      Jeder Cannabiswert heute mindestens -15% (Aphria -38%, Canopy und Arurora -23% etc.) und C21 hält sich bei +2%, starker Cashbestand und solides Unternehmen und das seit Jahren!
      C21 Investments | 1,970 $
      Avatar
      schrieb am 26.02.21 15:08:06
      Beitrag Nr. 93 ()
      C21 Investments | 1,474 $
      Avatar
      schrieb am 30.04.21 11:50:48
      Beitrag Nr. 94 ()


      Sehr interessanter Vergleich zwischen C21 und Planet13.

      Originallink: https://twitter.com/junglejava1/status/1386476624078573571
      C21 Investments | 1,040 $
      Avatar
      schrieb am 29.06.21 15:22:41
      Beitrag Nr. 95 ()
      Rekordquartal!

      Q1 Highlights (February 1, 2021 to April 30, 2021):

      Revenue of $9.2 million – same store sales in Nevada up 28% over the same period last year, with a record daily revenue run rate of $98,600 per day at the Nevada dispensaries
      Gross Profit of $4.8 million – Gross Margin (BFVA) of 49% with Nevada Operations at 55% (BFVA)
      Operating Cash Flow1 of $2.9 million – up 150% from Q1 2020
      Adjusted EBITDA1 of $2.6 million – 148% higher than Q1 2020
      Net Income of $4.4 million; record Earnings Per Share of $0.04

      https://ceo.ca/@newswire/c21-investments-announces-q1-result…
      C21 Investments | 0,997 $


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.
      C21 Investments - Superstarker Potdeal